Paloma Partners Management CO Ani Pharmaceuticals Inc Transaction History

Paloma Partners Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$30.35 - $67.14 $135,755 - $300,317	-4,473 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$55.65 - $79.83 $70,564 - $101,224	1,268 Added 39.56%	4,473 $276,000
Q3 2019 Nov 14, 2019	BUY	$64.7 - $85.39 $207,363 - $273,674	3,205 New	3,205 $234,000
Q2 2019 Aug 14, 2019	SELL	$67.77 - $82.2 $282,194 - $342,280	-4,164 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.83 - $70.54 $190,836 - $293,728	4,164 New	4,164 $294,000
Q4 2018 Feb 14, 2019	SELL	$41.17 - $56.44 $173,902 - $238,402	-4,224 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$52.95 - $71.34 $223,660 - $301,340	4,224 New	4,224 $239,000

211

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.